John W. Huemoeller II - Mar 15, 2024 Form 4/A Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Executive Officer, Director
Signature
/s/ John W. Huemoeller II
Stock symbol
AXIM
Transactions as of
Mar 15, 2024
Transactions value $
$125,000,000,000
Form type
4/A
Date filed
3/19/2024, 07:59 PM
Date Of Original Report
Mar 19, 2024
Previous filing
Sep 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note Award $62.5B +250K +0.84% $250,000.00* 30M Mar 15, 2024 Common Stock 25M $0.01 Direct F1
transaction AXIM Convertible Note Award $62.5B +250K +0.59% $250,000.00* 42.5M Mar 15, 2024 Common Stock 12.5M $0.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired an Amended Convertible Promissory Note in the face amount of $250,000. The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share.
F2 Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share.